Sensitization to docetaxel in prostate cancer cells by green tea and quercetin

Journal of Nutritional Biochemistry

Volumn 26, Issue 4, 2015, Pages 408-415

  Wang, Piwen ^a,b   Henning, Susanne M ^b   Heber, David ^b   Vadgama, Jaydutt V ^a,c  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Combination; Docetaxel; Green tea polyphenol; Prostate cancer; Quercetin

Indexed keywords

DOCETAXEL; EPIGALLOCATECHIN GALLATE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; QUERCETIN; STAT3 PROTEIN; CATECHIN; TAXOID; TEA;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CASTRATION RESISTANT PROSTATE CANCER; CHEMOSENSITIZATION; CONTROLLED STUDY; ENZYME INHIBITION; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IN VITRO STUDY; PROSTATE CANCER CELL LINE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TEA; ANALOGS AND DERIVATIVES; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; CHEMISTRY; DOWN REGULATION; DRUG EFFECTS; DRUG POTENTIATION; GENETICS; MALE; METABOLISM; PROSTATE TUMOR; TUMOR CELL LINE;

APOPTOSIS; CATECHIN; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; DRUG SYNERGISM; HUMANS; MALE; PHOSPHATIDYLINOSITOL 3-KINASES; PROSTATIC NEOPLASMS; QUERCETIN; TAXOIDS; TEA;

EID: 84925329908     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2014.11.017     Document Type: Article

References (44)

1. American Cancer Society Cancer facts & figures 2014 2014, American Cancer Society, Atlanta, GA.
2. Chen Y., Sawyers C.L., Scher H.I. Targeting the androgen receptor pathway in prostate cancer. Curr Opin Pharmacol 2008, 8:440-448.
3. Morgan T.M., Koreckij T.D., Corey E. Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathway. Curr Cancer Drug Targets 2009, 9:237-249.
4. Bellmunt J., Oh W.K. Castration-resistant prostate cancer: new science and therapeutic prospects. Ther Adv Med Oncol 2010, 2:189-207.
5. Galletti E., Magnani M., Renzulli M.L., Botta M. Paclitaxel and docetaxel resistance: molecular mechanisms and development of new generation taxanes. ChemMedChem 2007, 2:920-942.
6. Codony-Servat J., Marin-Aguilera M., Visa L., Garcia-Albeniz X., Pineda E., Fernandez P.L., et al. Nuclear factor-kappa B and interleukin-6 related docetaxel resistance in castration-resistant prostate cancer. Prostate 2013, 73(5):512-521.
7. van Oosterom A.T., Schrijvers D., Schriivers D. Docetaxel (Taxotere), a review of preclinical and clinical experience. Part II: clinical experience. Anticancer Drugs 1995, 6:356-368.
8. Lambert J.D., Yang C.S. Cancer chemopreventive activity and bioavailability of tea and tea polyphenols. Mutat Res 2003, 523-524:201-208.
9. Henning S.M., Wang P., Heber D. Chemopreventive effects of tea in prostate cancer: green tea versus black tea. Mol Nutr Food Res 2011, 55:905-920.
10. Yang C.S., Wang X. Green tea and cancer prevention. Nutr Cancer 2010, 62:931-937.
11. Gupta S., Ahmad N., Nieminen A.L., Mukhtar H. Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells. Toxicol Appl Pharmacol 2000, 164:82-90.
12. Hastak K., Gupta S., Ahmad N., Agarwal M.K., Agarwal M.L., Mukhtar H. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells. Oncogene 2003, 22:4851-4859.
13. Gupta S., Hastak K., Ahmad N., Lewin J.S., Mukhtar H. Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Natl Acad Sci U S A 2001, 98:10350-10355.
14. Bettuzzi S., Brausi M., Rizzi F., Castagnetti G., Peracchia G., Corti A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res 2006, 66:1234-1240.
15. McLarty J., Bigelow R.L., Smith M., Elmajian D., Ankem M., Cardelli J.A. Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro. Cancer Prev Res (Phila Pa) 2009, 2:673-682.
16. Yang C.S., Wang X., Lu G., Picinich S.C. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 2009, 9:429-439.
17. Wang P., Heber D., Henning S.M. Quercetin increased the antiproliferative activity of green tea polyphenol (-)-epigallocatechin gallate in prostate cancer cells. Nutr Cancer 2012, 64:580-587.
18. Wang P., Heber D., Henning S.M. Quercetin increased bioavailability and decreased methylation of green tea polyphenols in vitro and in vivo. Food Funct 2012, 3:635-642.
19. Wang P., Vadgama J.V., Said J.W., Magyar C.E., Doan N., Heber D., et al. Enhanced inhibition of prostate cancer xenograft tumor growth by combining quercetin and green tea. J Nutr Biochem 2014, 25:73-80.
20. van Zanden J.J., Wortelboer H.M., Bijlsma S., Punt A., Usta M., Bladeren P.J., et al. Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2. Biochem Pharmacol 2005, 69:699-708.
21. Nagai M., Conney A.H., Zhu B.T. Strong inhibitory effects of common tea catechins and bioflavonoids on the O-methylation of catechol estrogens catalyzed by human liver cytosolic catechol-O-methyltransferase. Drug Metab Dispos 2004, 32:497-504.
22. Singh A., Naidu P.S., Kulkarni S.K. Quercetin potentiates l-Dopa reversal of drug-induced catalepsy in rats: possible COMT/MAO inhibition. Pharmacology 2003, 68:81-88.
23. Kim K.A., Park P.W., Park J.Y. Short-term effect of quercetin on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein, in healthy volunteers. Eur J Clin Pharmacol 2009, 65:609-614.
24. Vijayababu M.R., Arunkumar A., Kanagaraj P., Venkataraman P., Krishnamoorthy G., Arunakaran J. Quercetin downregulates matrix metalloproteinases 2 and 9 proteins expression in prostate cancer cells (PC-3). Mol Cell Biochem 2006, 287:109-116.
25. Aalinkeel R., Bindukumar B., Reynolds J.L., Sykes D.E., Mahajan S.D., Chadha K.C., et al. The dietary bioflavonoid, quercetin, selectively induces apoptosis of prostate cancer cells by down-regulating the expression of heat shock protein 90. Prostate 2008, 68:1773-1789.
26. Vijayababu M.R., Arunkumar A., Kanagaraj P., Arunakaran J. Effects of quercetin on insulin-like growth factors (IGFs) and their binding protein-3 (IGFBP-3) secretion and induction of apoptosis in human prostate cancer cells. J Carcinog 2006, 5:10.
27. Xing N., Chen Y., Mitchell S.H., Young C.Y. Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells. Carcinogenesis 2001, 22:409-414.
28. Yang G.Y., Liao J., Li C., Chung J., Yurkow E.J., Ho C.T., et al. Effect of black and green tea polyphenols on c-jun phosphorylation and H(2)O(2) production in transformed and non-transformed human bronchial cell lines: possible mechanisms of cell growth inhibition and apoptosis induction. Carcinogenesis 2000, 21:2035-2039.
29. Chan L., Zhong X., Qiu J., Li P., Lin B. Cellometer vision as an alternative to flow cytometry for cell cycle analysis, mitochondrial potential, and immunophenotyping. Cytometry A 2011, 79:507-517.
30. Chan L.L., Lai N., Wang E., Smith T., Yang X., Lin B. A rapid detection method for apoptosis and necrosis measurement using the Cellometer imaging cytometry. Apoptosis 2011, 16:1295-1303.
31. Wang P., Aronson W.J., Huang M., Zhang Y., Lee R.P., Heber D., et al. Green tea polyphenols and metabolites in prostatectomy tissue: implications for cancer prevention. Cancer Prev Res (Phila Pa) 2010, 3:985-993.
32. Lochter A., Srebrow A., Sympson C.J., Terracio N., Werb Z., Bissell M.J. Misregulation of stromelysin-1 expression in mouse mammary tumor cells accompanies acquisition of stromelysin-1-dependent invasive properties. J Biol Chem 1997, 272:5007-5015.
33. Patrawala L., Calhoun T., Schneider-Broussard R., Li H., Bhatia B., Tang S., et al. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 2006, 25:1696-1708.
34. Chou T.C. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 2010, 70:440-446.
35. Vishnu P., Tan W.W. Update on options for treatment of metastatic castration-resistant prostate cancer. Oncol Targets Ther 2010, 3:39-51.
36. Hasima N., Aggarwal B.B. Cancer-linked targets modulated by curcumin. Int J Biochem Mol Biol 2012, 3:328-351.
37. Cross S.E., Jin Y.S., Lu Q.Y., Rao J., Gimzewski J.K. Green tea extract selectively targets nanomechanics of live metastatic cancer cells. Nanotechnology 2011, 22:215101.
38. Gibellini L., Pinti M., Nasi M., Montagna J.P., De Biasi S., Roat E., et al. Quercetin and cancer chemoprevention. Evid Based Complement Alternat Med 2011, 2011:591356.
39. Liotta L.A., Stetler-Stevenson W.G. Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 1991, 51:5054s-5059s.
40. Klampfer L. Signal transducers and activators of transcription (STATs): novel targets of chemopreventive and chemotherapeutic drugs. Curr Cancer Drug Targets 2006, 6:107-121.
41. Tang S.N., Fu J., Shankar S., Srivastava R.K. EGCG enhances the therapeutic potential of gemcitabine and CP690550 by inhibiting STAT3 signaling pathway in human pancreatic cancer. PLoS One 2012, 7:e31067.
42. Hurt E.M., Kawasaki B.T., Klarmann G.J., Thomas S.B., Farrar W.L. CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. Br J Cancer 2008, 98:756-765.
43. Tang S.N., Singh C., Nall D., Meeker D., Shankar S., Srivastava R.K. The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition. J Mol Signal 2010, 5:14.
44. Stearns M.E., Wang M. Synergistic effects of the green tea extract epigallocatechin-3-gallate and taxane in eradication of malignant human prostate tumors. Transl Oncol 2011, 4:147-156.